4//SEC Filing
Burgin Jonathan 4
Accession 0001140361-12-017923
CIK 0001451980other
Filed
Mar 27, 8:00 PM ET
Accepted
Mar 28, 5:56 PM ET
Size
5.6 KB
Accession
0001140361-12-017923
Insider Transaction Report
Form 4
BIOCANCELL THERAPEUTICS INC.BICL.TA
Burgin Jonathan
Chief Financial Officer
Transactions
- Award
Employee Options
2011-09-27+300,000→ 300,000 totalExp: 2021-09-27→ Common Stock (300,000 underlying)
Footnotes (2)
- [F1]The exercise price is 2.90 NIS per share.
- [F2]13,750 options shall vest and be exercisable at the end of each calendar quarter, from June 30, 2011 until 220,000 options are vested or until vesting is terminated in accordance with the terms of the options. An additional 80,000 options shall vest and be exercisable upon achievement of a pre-determined milestone.
Documents
Issuer
BIOCANCELL THERAPEUTICS INC.
CIK 0001451980
Entity typeother
Related Parties
1- filerCIK 0001519448
Filing Metadata
- Form type
- 4
- Filed
- Mar 27, 8:00 PM ET
- Accepted
- Mar 28, 5:56 PM ET
- Size
- 5.6 KB